Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference Sep 23, 2024 08:00AM
Solid Biosciences to Participate at Upcoming Investor Conferences Sep 20, 2023 08:00AM
Solid Biosciences to Participate in Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit Apr 21, 2023 08:00AM
Solid Biosciences to Participate at Upcoming Investor Conferences Sep 29, 2022 08:00AM
Solid Biosciences (SLDB) PT Lowered to $17 at Chardan Capital Markets, Keeps 'Buy' Rating Amid SGT-001 Data Sep 24, 2021 07:47AM


Sep 20, 2021 04:01PM Solid Biosciences to Participate at Upcoming Investor Conferences
Apr 20, 2021 07:30AM Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 5th Annual Genetic Medicines Manufacturing Summit
Mar 23, 2021 04:22PM Solid Biosciences Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
Mar 19, 2021 06:02AM Solid Biosciences (SLDB) Prices 21.74M Share Common Offering at $5.75/Sh
Mar 18, 2021 09:14PM Solid Biosciences Announces Pricing of Public Offering of Common Stock
Mar 17, 2021 04:20PM Solid Biosciences (SLDB) to Offer $85M in Common Stock
Mar 17, 2021 04:20PM Solid Biosciences Announces Proposed Public Offering of Common Stock
Mar 16, 2021 11:47AM Solid Biosciences (SLDB) PT Raised to $20 at Chardan Capital Markets
Jan 8, 2021 01:33PM Buy Solid Biosciences (SLDB) on Weakness - Chardan Capital
Oct 2, 2020 07:30AM Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 4th Annual Genetic Medicines Conference
Oct 1, 2020 10:55AM Solid Biosciences (SLDB) PT Raised to $12.50 at Chardan Capital Markets
Oct 2, 2019 07:30AM Solid Biosciences to Participate in the Chardan 3rd Annual Genetic Medicines Conference
Sep 10, 2019 04:01PM Solid Biosciences (SLDB) PT Raised to $15 at Chardan Capital Markets
Aug 16, 2019 08:04AM Chardan Capital Markets Upgrades Solid Biosciences (SLDB) to Buy
May 14, 2019 09:25AM Chardan Capital Markets Downgrades Solid Biosciences (SLDB) to Neutral
Feb 7, 2019 10:18AM Solid Biosciences (SLDB) PT Lowered to $15 at Chardan Capital Markets
Oct 5, 2018 04:05PM Solid Biosciences to Present at the Chardan Genetic Medicines Conference
Jun 25, 2018 07:15AM Solid Biosciences (SLDB) PT Raised to $60 at Chardan Capital Markets
Jun 18, 2018 09:55AM Solid Biosciences (SLDB): Removal of Clinical Hold a 'Clear Positive' - Chardan Capital Markets
Feb 21, 2018 06:40AM Chardan Capital Markets Starts Solid Biosciences (SLDB) at Buy
Jan 30, 2018 04:05PM Solid Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option
Jan 26, 2018 11:35AM Solid Biosciences (SLDB) IPO Opens Up 59%
Jan 26, 2018 05:42AM Solid Biosciences Inc. (SLDB) Prices 7.81M Share IPO Offering at $16/Sh
Jan 25, 2018 06:56PM Solid Biosciences Announces Pricing of Initial Public Offering
Dec 29, 2017 03:44PM Solid Biosciences Files $100M NASDAQ IPO; Plans to List Under Ticker 'SLDB'